Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frank Buttgereit

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Drug Dose-Response Relationship

Anatomy

Physiology

Procedures

Differential Diagnosis

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
37
Burmester, Gerd
11
Hiepe, Falk
8
Loddenkemper, Konstanze
8
Perka, Carsten
7
Tripmacher, Robert
6
Gaber, Timo
5
Krocker, Doerte
5
Huscher, Doerte
5
Scheffold, Alexander
4
Spies, Cornelia
4
Straub, Rainer
4
Radbruch, Andreas
4
Schuchmann, Sebastian
4
Hommes, Daan
4
Löwenberg, Mark

Sign-in to see all Coauthors

Publications

TOP 3
Buttgereit Frank; Zhou Hong; Kalak Robert; Gaber Timo; Spies Cornelia M; Huscher Dörte; Straub Ranier H; Modzelewski James; Dunstan Colin R; Seibel Markus J
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
Dose-related patterns of glucocorticoid-induced side effects.
Kolar P; Buttgereit F
[EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frank Buttgereit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Buttgereit Frank; Zhou Hong; Kalak Robert; Gaber Timo; Spies Cornelia M; Huscher Dörte; Straub Ranier H; Modzelewski James; Dunstan Colin R; Seibel Markus J
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Arthritis and rheumatism 2009;60(7):1998-2007.
2009: Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
Dose-related patterns of glucocorticoid-induced side effects.
Annals of the rheumatic diseases 2009;68(7):1119-24.
2009: Kolar P; Buttgereit F
[EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases]
Zeitschrift für Rheumatologie 2009;68(4):349-52.
2009: Kolar P; Lach S; Gaber T; Maschmeyer P; Dziurla R; Tripmacher R; Krocker D; Matziolis G; Perka C; Burmester G-R; Buttgereit F
Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells.
Clinical and experimental rheumatology 2009;27(1):99-107.
2008: Dziurla R; Buttgereit F
[Glucocorticoids in rheumatology]
Zeitschrift für Rheumatologie 2008;67(7):583-91; quiz 592.
2008: Stahn Cindy; Buttgereit Frank
Genomic and nongenomic effects of glucocorticoids.
Nature clinical practice. Rheumatology 2008;4(10):525-33.
2008: Löwenberg Mark; Stahn Cindy; Hommes Daniel W; Buttgereit Frank
Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Steroids 2008;73(9-10):1025-9.
2008: Buttgereit Frank; Zhou Hong; Seibel Markus J
Arthritis and endogenous glucocorticoids: the emerging role of the 11beta-HSD enzymes.
Annals of the rheumatic diseases 2008;67(9):1201-3.
2008: Cutolo Maurizio; Straub Rainer H; Buttgereit Frank
Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside.
Annals of the rheumatic diseases 2008;67(7):905-8.
2008: Pischon N; Pischon T; Kröger J; Gülmez E; Kleber B-M; Bernimoulin J-P; Landau H; Brinkmann P-G; Schlattmann P; Zernicke J; Buttgereit F; Detert J
Association among rheumatoid arthritis, oral hygiene, and periodontitis.
Journal of periodontology 2008;79(6):979-86.
2008: Tripmacher Robert; Gaber Timo; Dziurla René; Häupl Thomas; Erekul Kerem; Grützkau Andreas; Tschirschmann Miriam; Scheffold Alexander; Radbruch Andreas; Burmester Gerd-Rüdiger; Buttgereit Frank
Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production.
European journal of immunology 2008;38(6):1631-42.
2008: Krocker D; Ullrich H; Buttgereit F; Perka C
[Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis]
Der Orthopäde 2008;37(5):435-9.
2008: Buttgereit Frank; Doering Gisela; Schaeffler Achim; Witte Stephan; Sierakowski Stanislaw; Gromnica-Ihle Erika; Jeka Slawomir; Krueger Klaus; Szechinski Jacek; Alten Rieke
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
Lancet 2008;371(9608):205-14.
2008: Loddenkemper Konstanze; Hoyer Bimba; Loddenkemper Christoph; Hermann Kay-Geert; Rogalla Patrick; Förster Gregor; Buttgereit Frank; Hiepe Falk; Burmester Gerd-Rüdiger
A case of Erdheim-Chester disease initially mistaken for Ormond's disease.
Nature clinical practice. Rheumatology 2008;4(1):50-5.
2007: Hoes J N; Jacobs J W G; Boers M; Boumpas D; Buttgereit F; Caeyers N; Choy E H; Cutolo M; Da Silva J A P; Esselens G; Guillevin L; Hafstrom I; Kirwan J R; Rovensky J; Russell A; Saag K G; Svensson B; Westhovens R; Zeidler H; Bijlsma J W J
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
Annals of the rheumatic diseases 2007;66(12):1560-7.
2007: Buttgereit F; Burmester G; Bijlsma J W;
[Disease-modifying effects of glucocorticoids in rheumatoid arthritis]
Zeitschrift für Rheumatologie 2007;66(6):522-4.
2007: Stahn Cindy; Löwenberg Mark; Hommes Daniel W; Buttgereit Frank
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Molecular and cellular endocrinology 2007;275(1-2):71-8.
2007: Oelzner P; Buttgereit F; Demary W; Franck H; Kern P; Hein G
[The mechanism of bone loss in rheumatoid arthritis. Description based on a case report]
Zeitschrift für Rheumatologie 2007;66(4):337-40.
2006: Tryc Anita B; Spies Cornelia M; Schneider Udo; Kunkel Desiree; Berki Timea; Sieper Joachim; Burmester Gerd-Rüdiger; Radbruch Andreas; Scheffold Alexander; Buttgereit Frank
Membrane glucocorticoid receptor expression on peripheral blood mononuclear cells in patients with ankylosing spondylitis.
The Journal of rheumatology 2006;33(11):2249-53.
2006: Löwenberg Mark; Verhaar Auke P; Bilderbeek Joyce; Marle Jan van; Buttgereit Frank; Peppelenbosch Maikel P; van Deventer Sander J; Hommes Daniel W
Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN.
EMBO reports 2006;7(10):1023-9.
2006: Dreher R; Buttgereit F; Demary W; Görtz B; Hein G; Kern P; Schulz A
[Insufficiency fractures in rheumatology. Case report and overview]
Zeitschrift für Rheumatologie 2006;65(5):417-23.
2006: Spies C M; Schaumann D H S; Berki T; Mayer K; Jakstadt M; Huscher D; Wunder C; Burmester G-R; Radbruch A; Lauster R; Scheffold A; Buttgereit F
Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway.
Annals of the rheumatic diseases 2006;65(9):1139-46.
2006: Wiontzek M; Matziolis G; Schuchmann S; Gaber T; Krocker D; Duda G; Burmester G-R; Perka C; Buttgereit F
Effects of dexamethasone and celecoxib on calcium homeostasis and expression of cyclooxygenase-2 mRNA in MG-63 human osteosarcoma cells.
Clinical and experimental rheumatology 2006;24(4):366-72.
2006: Krocker D; Matziolis G; Tuischer J; Funk J; Tohtz S; Buttgereit F; Perka C
[Reduction of arthrosis associated knee pain through a single intra-articular injection of synthetic hyaluronic acid]
Zeitschrift für Rheumatologie 2006;65(4):327-31.
2006: Krocker Dörte; Perka Carsten; Tuischer Jens; Funk Julia; Tohtz Stephan; Buttgereit Frank; Matziolis Georg
Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells.
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(7):563-9.
2006: Scherer H U; van Landeghem F K H; Buttgereit F
[Polyarteritis nodosa - a "classical" case]
Zeitschrift für Rheumatologie 2006;65(4):311-4.
2006: Song In-Ho; Buttgereit Frank
Non-genomic glucocorticoid effects to provide the basis for new drug developments.
Molecular and cellular endocrinology 2006;246(1-2):142-6.
2006: Schultz O; Ruckert R; Burmester G; Buttgereit F
[Acute mesenteric ischemia in a patient with relapsing polychondritis]
Zeitschrift für Rheumatologie 2006;65(1):63-8.
2006: Naumann Lydia; Feist Eugen; Straub Rainer H; Burmester Gerd-Rüdiger; Buttgereit Frank
Potencies of topical glucocorticoids to mediate genomic and nongenomic effects on human peripheral blood mononuclear cells.
Biochemical pharmacology 2006;71(4):530-9.
2006: Loddenkemper Konstanze; Bohl Nicole; Perka Carsten; Burmester Gerd-Rüdiger; Buttgereit Frank
Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.
Rheumatology international 2006;26(4):331-6.
2005: Thiele Katja; Buttgereit Frank; Huscher Doerte; Zink Angela;
Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.
Arthritis and rheumatism 2005;53(5):740-7.
2005: Löwenberg Mark; Tuynman Jurriaan; Bilderbeek Joyce; Gaber Timo; Buttgereit Frank; van Deventer Sander; Peppelenbosch Maikel; Hommes Daniel
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn.
Blood 2005;106(5):1703-10.
2005: Song In-Ho; Gold Ralf; Straub Rainer H; Burmester Gerd-Rüdiger; Buttgereit Frank
New glucocorticoids on the horizon: repress, don't activate!
The Journal of rheumatology 2005;32(7):1199-1207.
2005: Loddenkemper K; Enzweiler C; Loddenkemper C; Backhaus M; Burmester G-R; Buttgereit F
Granulomatous synovialitis with erosions in the shoulder joint: a rare case of polyarthritis caused by Mycobacterium kansasii.
Annals of the rheumatic diseases 2005;64(7):1088-90.
2005: Gaber T; Dziurla R; Tripmacher R; Burmester G R; Buttgereit F
Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!
Annals of the rheumatic diseases 2005;64(7):971-80.
2005: Buttgereit F; Song I-H; Straub R H; Burmester G-R
[Current insights into the development of new glucocorticoid receptor ligands]
Zeitschrift für Rheumatologie 2005;64(3):170-6.
2005: Thiele K; Buttgereit F; Huscher D; Zink A;
[Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany]
Zeitschrift für Rheumatologie 2005;64(3):149-54.
2005: Buttgereit Frank; Burmester Gerd-Rüdiger; Lipworth Brian J
Optimised glucocorticoid therapy: the sharpening of an old spear.
Lancet 2005;365(9461):801-3.
2005: Bijlsma Johannes W J; Saag Kenneth G; Buttgereit Frank; da Silva José A P
Developments in glucocorticoid therapy.
Rheumatic diseases clinics of North America 2005;31(1):1-17, vii.
2005: Buttgereit F; Saag K G; Cutolo M; da Silva J A P; Bijlsma J W J
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.
Scandinavian journal of rheumatology 2005;34(1):14-21.
2004: Buttgereit Frank; Straub Rainer H; Wehling Martin; Burmester Gerd-Rüdiger
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.
Arthritis and rheumatism 2004;50(11):3408-17.
2004: Franck H; Braun J; Buttgereit F; Dreher R; Hein G; Kekow J
[Specialties in therapy of osteoporosis in inflammatory joint disease]
Zeitschrift für Rheumatologie 2004;63(3):223-9.
2004: Schuchmann S; Wiontzek M; Burmester G R; Buttgereit F
Modulation of intracellular calcium signaling and mitochondrial function in cultured osteoblastic cells by dexamethasone and celecoxib during mechanical stimulation.
Clinical and experimental rheumatology 2004;22(2):184-96.
2004: Bartholome Burkhard; Spies Cornelia M; Gaber Timo; Schuchmann Sebastian; Berki Timea; Kunkel Désirée; Bienert Maren; Radbruch Andreas; Burmester Gerd-Rüdiger; Lauster Roland; Scheffold Alexander; Buttgereit Frank
Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(1):70-80.
2003: Schultz Olaf; Buttgereit Frank
[Selective COX-2 inhibition improves endothelial function in coronary artery disease]
Zeitschrift für Rheumatologie 2003;62(4):422-4.
2003: Schultz O; Schuchmann S; Burmester G-R; Buttgereit F
Case number 26: systemic idiopathic fibrosis associated with aortitis.
Annals of the rheumatic diseases 2003;62(5):486.
2003: Kuhnke A; Burmester G-R; Krauss S; Buttgereit F
Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment.
Annals of the rheumatic diseases 2003;62(2):133-9.
2003: Loddenkemper K; Grauer A; Burmester G R; Buttgereit F
Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
Clinical and experimental rheumatology 2003;21(1):19-26.
2002: Buttgereit F; da Silva J A P; Boers M; Burmester G-R; Cutolo M; Jacobs J; Kirwan J; Köhler L; Van Riel P; Vischer T; Bijlsma J W J
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.
Annals of the rheumatic diseases 2002;61(8):718-22.
2002: Loddenkemper K; Perka C; Burmester G-R; Buttgereit F
Coincidence of asymptomatic avascular necrosis and fracture of the femoral neck: a rare combination of glucocorticoid induced side effects.
Annals of the rheumatic diseases 2002;61(7):665-6.
2002: Lunemann Jan D; Buttgereit Frank; Tripmacher Robert; Baerwald Christoph G O; Burmester Gerd-Rudiger; Krause Andreas
Effects of norepinephrine on oxygen consumption of quiescent and activated human peripheral blood mononuclear cells.
Annals of the New York Academy of Sciences 2002;966():365-8.
2002: Buttgereit Frank; Scheffold Alexander
Rapid glucocorticoid effects on immune cells.
Steroids 2002;67(6):529-34.
2002: Loddenkemper K; Buttgereit F
[Chrysiasis]
Zeitschrift für Rheumatologie 2002;61(2):173-4.
2001: Patschan D; Loddenkemper K; Buttgereit F
Molecular mechanisms of glucocorticoid-induced osteoporosis.
Bone 2001;29(6):498-505.
2001: Lünemann J D; Buttgereit F; Tripmacher R; Baerwald C G; Burmester G R; Krause A
Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptors.
Bioscience reports 2001;21(5):627-35.
2001: Loddenkemper K; Buttgereit F
[Chrysiasis]
Zeitschrift für Rheumatologie 2001;60(5):359-60.
2001: Scharla S H; Buttgereit F; Dreher R; Felsenberg D; Franck H; Hein G; Lemmel E M; Rau R; Sieper J; Braun J
[Preliminary consensus statement on glucocorticoid-induced osteoporosis]
Zeitschrift für Rheumatologie 2001;60(2):96-9.
2001: Buttgereit F
[Mechanism of action and effects of glucocorticoids]
Zeitschrift für Rheumatologie 2001;60(2):117-9.
2001: Schmid D; Burmester G R; Tripmacher R; Fici G; von Voigtlander P; Buttgereit F
Short-term effects of the 21-aminosteroid lazaroid tirilazad mesylate (PNU-74006F) and the pyrrolopyrimidine lazaroid PNU-101033E on energy metabolism of human peripheral blood mononuclear cells.
Bioscience reports 2001;21(1):101-10.
2000: Schmid D; Burmester G R; Tripmacher R; Kuhnke A; Buttgereit F
Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states.
Bioscience reports 2000;20(4):289-302.
2000: Schottelius A; Wedel S; Weltrich R; Rohde W; Buttgereit F; Schreiber S; Lochs H
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease.
The American journal of gastroenterology 2000;95(8):1994-9.
2000: Sanden S; Tripmacher R; Weltrich R; Rohde W; Hiepe F; Burmester G R; Buttgereit F
Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.
The Journal of rheumatology 2000;27(5):1265-70.
2000: Buttgereit F; Burmester G R; Brand M D
Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids.
Biochemical pharmacology 2000;59(6):597-603.
2000: Buttgereit F
Mechanisms and clinical relevance of nongenomic glucocorticoid actions.
Zeitschrift für Rheumatologie 2000;59 Suppl 2():II/119-23.
1999: Buttgereit F; Brand M D; Burmester G R
Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.
Biochemical pharmacology 1999;58(2):363-8.
1999: Grünewald T; Burmester G R; Schüler-Maué W; Hiepe F; Buttgereit F
Anti-phospholipid antibodies and CD5+ B cells in HIV infection.
Clinical and experimental immunology 1999;115(3):464-71.
1998: Perka C; Buttgereit F; Backhaus M
[Pregnancy-induced algodystrophy]
Zeitschrift für Rheumatologie 1998;57(6):399-408.
1998: Buttgereit F; Wermke W; Hiepe F; Burmester G R
Clinical image: Isolated arteritis of the superior mesenteric artery with positive perinuclear antineutrophil cytoplasmic antibody.
Arthritis and rheumatism 1998;41(9):1701.
1997: Spallek G; Buttgereit F; Audring H; Hiepe F
[Persistent facial swelling of unclear etiology. The differential diagnostic considerations]
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1997;48(11):828-33.
1997: Buttgereit F; Grünewald T; Schüler-Maué W; Burmester G R; Hiepe F
Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases.
Clinical rheumatology 1997;16(6):562-9.
1997: Buttgereit F; Hiepe F; Burmester G R
[The therapeutic potential of lazaroids (21-aminosteroids). A recent survey]
Deutsche medizinische Wochenschrift (1946) 1997;122(44):1363-7.
1997: Buttgereit F; Krauss S; Brand M D
Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytes.
The Biochemical journal 1997;326 ( Pt 2)():329-32.
1997: Buttgereit F; Kaschke O; Krause A; Burmester G R
[Protracted course of polychondritis as the etiology of progressive nose deformity, subglottic tracheal stenosis and inner ear hearing loss]
Laryngo- rhino- otologie 1997;76(1):46-9.
1996: Buttgereit F; Dimmeler S; Neugebauer E; Burmester G R
[Mechanisms of action of high-dosage glucocorticoid therapy]
Deutsche medizinische Wochenschrift (1946) 1996;121(8):248-52.
1995: Buttgereit F; Brink I; Thiele B; Burmester G R; Hiepe F; Hall E D
Effects of methylprednisolone and 21-aminosteroids on mitogen-induced interleukin-6 and tumor necrosis factor-alpha production in human peripheral blood mononuclear cells.
The Journal of pharmacology and experimental therapeutics 1995;275(2):850-3.
1994: Buttgereit F; Künzel K; Tietz H J; Sajkiewicz K; Gellert K; Hiepe F; Burmester G R
Persistent pulmonary lesion in a patient with rheumatoid arthritis.
Annals of the rheumatic diseases 1994;53(12):798-800.
1994: Buttgereit F; Müller M; Wolbart K; Thiele B; Hiepe F
The influence of methylprednisolone on the energy metabolism of Ehrlich ascites tumour cells.
Bioscience reports 1994;14(6):283-90.
1994: Buttgereit F
[Therapy of rheumatic diseases with methylprednisolone--mechanism of action and clinical applications]
Zeitschrift für ärztliche Fortbildung 1994;88(11):897-902.
1994: Buttgereit F; Janda J; Egert M; Hiepe F
[An unusual constellation of findings in polymyositis--differential diagnosis and clinical course]
Zeitschrift für Rheumatologie 1994;53(5):307-13.
1994: Buttgereit F; Grant A; Müller M; Brand M D
The effects of methylprednisolone on oxidative phosphorylation in Concanavalin-A-stimulated thymocytes. Top-down elasticity analysis and control analysis.
European journal of biochemistry / FEBS 1994;223(2):513-9.
1992: Buttgereit F; Hiepe F; Apostoloff E
[Multiple myeloma with antinuclear antibodies. Its course during cytostatic therapy]
Deutsche medizinische Wochenschrift (1946) 1992;117(21):819-22.

Sign-in to see more